Lipid lowering therapy in the elderly
Kaffarnik, H.; Schneider, J.
Münchener Medizinische Wochenschrift 125(28): 663-665
1983
ISSN/ISBN: 0341-3098 PMID: 6412133 Document Number: 198168
Document emailed within 1 workday
Related Documents
Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-4671997: What is new? Therapy with lipid lowering agents Der Internist 38(11 Suppl Therapie): 1-8
Kastelein, J.J.P. 2003: The future of lipid-lowering therapy: the big picture Netherlands Journal of Medicine 61(5 Suppl): 35-39
Nordmann, A.; Martina, B.; Keller, U.; Battegay, E. 1998: Lipid lowering therapy: new pathophysiologic aspects and clinical implications Schweizerische Medizinische Wochenschrift 128(17): 665-670
Radermecker, R.P.; Scheen, A.J. 2010: How to optimize lipid-lowering therapy: do not forget patient's non-compliance Revue Medicale de Liege 65(5-6): 311-317
Bonadei, I.; Vizzardi, E.; D'aloia, A.; Gelsomino, S.; De Cicco, G.; Lorusso, R.; Dei Cas, L. 2013: Aortic valve stenosis and lipid-lowering therapy: the state of the art Panminerva Medica 55(4): 391-395
Barth, J.D. 1995: Pixel or death: experience from clinical trials assessing lipid lowering therapy Canadian Journal of Cardiology 11 Suppl C: 9c
Lancellotti, P.; Pierard, L.A.; Scheen, A.J. 2015: Acute Coronary Syndrome and Lipid-Lowering Therapy. Does the Improve-It Study make Any Difference? Revue Medicale de Liege 70(9): 450-455
Truppo, C.; Keller, V.A.; Reusch, M.Teresa.; Pandya, B.; Bendich, D. 2003: The effect of a comprehensive, mail-based motivational program for patients receiving lipid-lowering therapy Managed Care Interface 16(3): 35-40 62
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19
Praipaisarnkit, K.; Wongpraparut, N.; Pongakasira, R. 2014: Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic Journal of the Medical Association of Thailand 97(Suppl 3): S147-S154
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
Rodenburg, J.; Vissers, M.N.; Daniels, S.R.; Wiegman, A.; Kastelein, J.J.P. 2004: Lipid-lowering medications Pediatric Endocrinology Reviews: Per 2(Suppl 1): 171-180
Wierzbicki, A.S. 1999: The role of lipid lowering in transplantation International Journal of Clinical Practice 53(1): 54-59
Tziomalos, K. 2016: Unresolved issues in lipid-lowering treatment Panminerva Medica 58(2): 191-195
Lawless, C.; Force, R. 1997: Lipid lowering in post-Mi patients with normal cholesterol Journal of Family Practice 44(1): 30
Rosenthal, J. 1989: Blood pressure and lipid lowering effects of terazosin Journal of Human Hypertension 3 Suppl. 2: 85-9; Discussion 90-1
Guo, Y.-f.; Hu, D.-y. 2007: Statins in lowering cholesterol in the elderly Zhonghua Nei Ke Za Zhi 46(11): 893-894
Jacotot, B. 1979: Biochemical and experimental aspects of the lipid-lowering drugs pharmacology La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(41-42): 1947-1955